Niche-induced Signaling in Progenitor B Cell Development

B 祖细胞发育中生态位诱导的信号转导

基本信息

  • 批准号:
    7889153
  • 负责人:
  • 金额:
    $ 42.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-11 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In the bone marrow (BM), progenitor B cell growth and survival depend on cues from distinct microenvironments, e.g. niches. Niche specific signals involving among others cytokines, chemokines and adhesion molecules, also influence the localization and migration of developing B cells in BM. The key findings of our preliminary studies are that Fak deletion in CD19-Cre Fak fl/fl mice leads to impairment of progenitor B cell development in BM and egress of pro-B cells into the peripheral circulation. In this application, we hypothesize that FAK functions as an integrator of niche-induced signaling regulating progenitor B cell fate. Three aims are proposed to test this hypothesis. Aim 1 will define how FAK regulates progenitor B cell growth and survival. Both in vitro methylcellulose based colony cell forming cell assays as well as in vivo adoptive transfer experiments will be used to examine the role of FAK in progenitor B cell cell cycle, proliferation, self-renewal, differentiation and apoptosis. To assess FAK function molecularly, the role of FAK in signaling pathways regulating progenitor B cell growth and survival will be defined. We will extend our findings from CD19-Cre Fak fl/fl mice and determine the effect of Fak deletion on progenitor B cell development in mb1- Cre EYFP mice, as they exhibit higher efficiency of Cre-mediated deletion beginning at the early pro-B cell stage. Aim 2 will define how FAK regulates the motility and distribution of progenitor B cell populations in distinct anatomical locations within the BM. Laser scanning cytometry (LSC) analysis of cryopreserved femurs will quantify and map the morphological position(s) of Fak wt and Fak-/- progenitor B cell populations in the diaphysis (endosteal vs. central medullary regions) and metaphyses of the BM. Multi-photon intravital microscopy (MP-IVM) will characterize in vivo the dynamic behavior of Fak wt and Fak-/- progenitor B cell populations and their interactions with adjacent cells in BM. Cell biological assays will be applied towards defining mechanisms for observed changes in Fak-/- progenitor B cell motility and distribution in BM. Aim 3: To define how FAK regulates the association of progenitor B cells with specific niche cell types. Niche cells, e.g. osteoblasts, vascular endothelial cells, IL-7 producing cells and CXCL12-abundant reticular (CAR) cells will be identified by immunohistology on longitudinal sections of femurs. LSC, in conjunction with fluorescent immunostaining of surface antigens for progenitor B and niche cells, will objectively quantify the relative frequency that Fak wt and Fak -/- progenitor B cells are found in close association with each niche cell type throughout the BM cavity. The importance of the CXCR4-FAK pathway in mediating progenitor B cell lodgement in specific BM compartments will be evaluated by treating Fak wt and Fak -/- mice with a CXCR4 antagonist (e.g., AMD3100), prior to LSC analyses. A better definition of environmental signals controlling B cell development and function will have important implications for research in pathogenesis and treatment of B cell disorders including leukemia and immunodeficiency. PUBLIC HEALTH RELEVANCE: FAK is a ubiquitously expressed cell signaling protein, which can regulate cell adhesion, growth and survival. We hypothesize that FAK functions as a key integrator of environmental signals necessary for the growth of normal and neoplastic B cells in the bone marrow. Thus, the research proposed here will provide important insight into previously unrecognized pathogenetic mechanisms of B cell leukemia as well as immunodeficiency syndromes.
描述(由申请人提供):在骨髓(BM)中,祖B细胞的生长和存活依赖于不同微环境的提示,例如生态位。包括其他细胞因子、趋化因子和粘附分子在内的生态位特异性信号也影响BM中发育中的B细胞的定位和迁移。我们初步研究的关键发现是CD19-Cre Fak fl/fl小鼠中Fak缺失导致BM中祖B细胞发育受损,并导致前B细胞进入外周循环。在这个应用中,我们假设FAK作为利基诱导的信号传导调节祖B细胞命运的整合者。为了验证这一假设,提出了三个目标。目的1将确定FAK如何调节祖细胞B细胞的生长和存活。体外甲基纤维素集落细胞形成实验和体内过继转移实验将用于研究FAK在祖细胞B细胞周期、增殖、自我更新、分化和凋亡中的作用。为了从分子上评估FAK的功能,我们将定义FAK在调节祖细胞生长和存活的信号通路中的作用。我们将在CD19-Cre Fak fl/fl小鼠中扩展我们的研究结果,并确定Fak缺失对mb1- Cre EYFP小鼠祖B细胞发育的影响,因为它们在早期前B细胞阶段就表现出更高的Cre介导的缺失效率。目的2将定义FAK如何调节BM内不同解剖位置的祖B细胞群的运动和分布。激光扫描细胞术(LSC)分析冷冻保存的股骨将量化和绘制Fak wt和Fak-/-祖B细胞群在骨干(髓内区与中央髓区)和BM的形而上学中的形态位置。多光子活体显微镜(MP-IVM)将表征Fak wt和Fak-/-祖B细胞群的体内动态行为及其与BM中邻近细胞的相互作用。细胞生物学测定将用于确定Fak-/-祖B细胞运动和分布在BM中观察到的变化的机制。目的3:确定FAK如何调节祖细胞B细胞与特定生态位细胞类型的关联。利用免疫组织学方法,在股骨纵切面上鉴定小龛细胞,如成骨细胞、血管内皮细胞、产生IL-7的细胞和富含cxcl12的网状(CAR)细胞。LSC结合祖细胞B和生态位细胞表面抗原的荧光免疫染色,将客观地量化Fak wt和Fak -/-祖细胞与BM腔内每种生态位细胞类型密切相关的相对频率。在LSC分析之前,将通过使用CXCR4拮抗剂(例如AMD3100)治疗Fak wt和Fak -/-小鼠来评估CXCR4- Fak通路在介导特定BM室中祖细胞沉积中的重要性。更好地定义控制B细胞发育和功能的环境信号将对研究包括白血病和免疫缺陷在内的B细胞疾病的发病机制和治疗具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leslie Eric Silberstein其他文献

Leslie Eric Silberstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leslie Eric Silberstein', 18)}}的其他基金

Molecular Mechanisms of Blood Cell Transfusion
血细胞输注的分子机制
  • 批准号:
    8289606
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Niche-induced Signaling in Progenitor B Cell Development
B 祖细胞发育中生态位诱导的信号转导
  • 批准号:
    8269062
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Niche-induced Signaling in Progenitor B Cell Development
B 祖细胞发育中生态位诱导的信号转导
  • 批准号:
    8089307
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
PACT
协议
  • 批准号:
    8163731
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
PACT
协议
  • 批准号:
    8607096
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
PACT
协议
  • 批准号:
    8429221
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Molecular Mechanisms of Blood Cell Transfusion
血细胞输注的分子机制
  • 批准号:
    8511787
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Molecular Mechanisms of Blood Cell Transfusion
血细胞输注的分子机制
  • 批准号:
    9294145
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Inflammatory modulation of CXCL12 expressing niche cells in bone marrow
骨髓中表达 CXCL12 的微环境细胞的炎症调节
  • 批准号:
    9072497
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9072494
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:

相似海外基金

Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
  • 批准号:
    20K08723
  • 财政年份:
    2020
  • 资助金额:
    $ 42.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
  • 批准号:
    9047400
  • 财政年份:
    2015
  • 资助金额:
    $ 42.88万
  • 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
  • 批准号:
    319114
  • 财政年份:
    2014
  • 资助金额:
    $ 42.88万
  • 项目类别:
    Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
  • 批准号:
    8595788
  • 财政年份:
    2013
  • 资助金额:
    $ 42.88万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8023518
  • 财政年份:
    2011
  • 资助金额:
    $ 42.88万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8404025
  • 财政年份:
    2011
  • 资助金额:
    $ 42.88万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8220724
  • 财政年份:
    2011
  • 资助金额:
    $ 42.88万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8599754
  • 财政年份:
    2011
  • 资助金额:
    $ 42.88万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8356701
  • 财政年份:
    2010
  • 资助金额:
    $ 42.88万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8166720
  • 财政年份:
    2009
  • 资助金额:
    $ 42.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了